A Phase 2 Study of Weekly Albumin-Bound Paclitaxel (Abraxane(®)) Given as a Two-Hour Infusion

PURPOSE: Paclitaxel is an effective therapy for patients with solid tumors. While the albumin-bound formulation eliminates the hypersensitivity reaction caused by the Cremaphor solvent, significant peripheral neuropathy persists when given over the standard 30-minute infusion time. We sought to dete...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Paik, Paul K., James, Leonard P., Riely, Gregory J., Azzoli, Christopher G., Miller, Vincent A., Ng, Kenneth K., Sima, Camelia S., Heelan, Robert T., Kris, Mark G., Moore, Erin, Rizvi, Naiyer A.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2011
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3581346/
https://ncbi.nlm.nih.gov/pubmed/21461889
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-011-1621-0
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg